Efficacy and safety of sacubitril/valsartan in patients on peritoneal dialysis: a systematic review and meta-analysis. [PDF]
Silva CLD +5 more
europepmc +1 more source
Bibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025). [PDF]
Liu P, He X, Luo X, Xie S, Li Y, Su B.
europepmc +1 more source
You evaluation of the PARACHUTE-HF trial: role of sacubitril/valsartan compared to enalapril on outcomes in patients with heart failure from Chagas' disease. [PDF]
Abramov D +5 more
europepmc +1 more source
Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring. [PDF]
Iwashima Y +4 more
europepmc +1 more source
Efficacy and Safety of Sacubitril/Valsartan Versus Enalapril in the Treatment of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]
Aljubeh R +6 more
europepmc +1 more source
Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis. [PDF]
Abhari AP +6 more
europepmc +1 more source
Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience. [PDF]
Yang L +9 more
europepmc +1 more source
Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. [PDF]
Jung K, Shin JY, Kim JH.
europepmc +1 more source
Drug-induced renal function deterioration in a patient with polyarteritis nodosa. [PDF]
Iturgoyen-Fuentes DP.
europepmc +1 more source
Sacubitril/valsartan facilitates recovery of cardiac function in a patient with peripartum cardiomyopathy: a case report. [PDF]
Saijo Y +4 more
europepmc +1 more source

